Related Experiment Video
Updated: Jul 2, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Cisplatin-associated thrombosis
Mariam Jafri1, Andrew Protheroe
1Department of Medical Oncology, Oxford University, Churchill Hospital, Oxford, UK. mariamjafri@hotmail.com
Abstract:
The discovery of cisplatin has made arguably the biggest contribution to cancer medicine, providing the basis for the chemotherapy treatment of many malignancies. In addition to well-documented toxicities such as neurotoxicity, cisplatin-induced vascular toxicity is becoming an increasing concern, with some authors describing it in up to 12% of patients. Given the efficacy of cisplatin, vascular toxicity represents a significant survivorship issue. We describe different manifestations of cisplatin-associated thrombosis and its putative pathophysiology.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Drugs that Destabilize Microtubules
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
